Clinical trial
Endometrial Cancer Vaginal Fluid Specimen Collection Study: "ENVISION"
NCT07544680 is registered in ClinicalTrials.gov with Exact Sciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endometrial Cancer Vaginal Fluid Specimen Collection Study: "ENVISION"
- Lead sponsor
- Exact Sciences Corporation
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 10, 2026
- Completion date
- April 24, 2028
- Enrollment
- 4,200 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
abnormal uterine bleeding (aub), atypical endometrial hyperplasia, endometrial cancer, endometrial hyperplasia with atypia, endometrial intraepithelial neoplasia